We are a dynamic research group based in Princeton University’s Omenn-Darling Bioengineering Institute. As molecular engineers, we integrate high throughput synthetic biology with computational approaches to develop next-generation tools for cellular engineering and therapeutic innovation. Our work involves the development of new technologies and deep learning models that enable programmable control over biomolecules, cells, and multicellular systems. We leverage the diversity of biology to discover modular parts for building synthetic circuits and use these circuits to reprogram cells. These platforms also serve as the foundation for high-throughput functional data collection, which fuels the training of foundation models in therapeutically relevant contexts.